Get In Touch

Triclabendazole Market: Introduction

  • Triclabendazole was first used to treat Fasciola hepatica infections in animals in the early 1980s. It has established itself as the primary anti-fluke medication on the market due to its strong action against immature flukes. Triclobendazole has recently been used to treat human cases of fascioliasis; and currently, it is the treatment of choice for this infection as well.
  • Triclabendazole became a generic drug because patents in many countries expired in the late 1990s. During that time, a lot of products were created. In the early 2000s, Agrovet Market Animal Health introduced Trivantel 15, a 15% triclabendazole suspension. Agrovet Market Animal Health also developed and launched the first triclabendazole injectable solution (in combination with ivermectin) in 2009. Fasiject Plus, a 36% triclabendazole and 0.6% ivermectin solution; is utilized to treat Fasciola hepatica (both immature and adult liver flukes), roundworms, and ectoparasite infections.

Key Drivers, Restrains, and Opportunities of Global Triclabendazole Market

  • Increase in prevalence of fascioliasis is driving the triclabendazole market. Fascioliasis is a foodborne trematode infection with a worldwide distribution. Fasciola infection has been reported in 81 countries, and is considered a neglected zoonotic disease by the World Health Organization. Two accepted species, Fasciola hepatica and Fasciola gigantica, infect a wide range of mammals including livestock and humans. It was estimated that between 2.6 million people were infected around the world with Fascioliasis. Given the emerging character of fascioliasis and reports of its expanding endemic areas, it is likely that the number of infections around the world surpasses previous estimates.
  • Fascioliasis is found in focal areas of more than 70 countries, in all continents except Antarctica. It is found in parts of Latin America, the Caribbean, Europe, the Middle East, Africa, Asia, and Oceania. Fasciola gigantica is found in fewer geographic regions. Human cases have been reported in the tropics, in parts of Africa and Asia, and also in Hawaii. Triclabendazole is indicated for the treatment of fascioliasis in patients aged 6 years old and above, which drives its market.
  • Governments of developing countries are making significant investments to modernize healthcare infrastructure, which is likely to increase access to health care. This is expected to increase the demand for Triclabendazole. Increase in prevalence of Fascioliasis in developing countries presents lucrative opportunities for the global Triclabendazole market.

North America to Capture Major Share of Global Triclabendazole Market

  • North America is expected to account for major share of the global Triclabendazole market due to high prevalence of Fascioliasis among the population. Moreover, well-established healthcare infrastructure and hub for key industry players are major factors boosting the Triclabendazole market in the region.
  • The Triclabendazole market in Asia Pacific is estimated to expand at a rapid pace during the forecast period owing to expansion of health care infrastructure. Moreover, surge in Fascioliasis infection is likely propel the market in the region.

Key Players Operating in Global Triclabendazole Market

The global Triclabendazole market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for products to treat Fascioliasis has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global Triclabendazole market.

Major players operating in the global Triclabendazole market are listed below:

  • Alivira Animal Health
  • Hangzhou Think Chemical
  • Hebei Veyong Animal Pharmaceutical
  • Hengdian Group Holding
  • Ipca Laboratories
  • Jiangsu Quality Horizons Pharmtech
  • Lasa Laboratory
  • Novartis pharmaceuticals
  • Procyon Life Science
  • Rakshit Drugs Private

Global Triclabendazole Market: Research Scope

Global Triclabendazole Market, by Product

  • Less than 98%
  • Less than 99%
  • Other

Global Triclabendazole Market, by Dosage Form

  • Tablet
  • Oral suspension
  • Oral Solution

Global Triclabendazole Market, by Age Group

  • Adult
  • Pediatric

Global Triclabendazole Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Triclabendazole Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Triclabendazole Market

Pre Book